The Biotech Growth Trust Plc - Correction : Transaction in Own Shares
Please note that the purchased price was
pence, as originally stated.
For immediate release
MARKET PURCHASE OF COMPANY’S OWN SHARES
Notification is given, pursuant to the authority granted at Annual General Meeting of the Company held on
Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 41,672,156. The Company does not currently hold any Ordinary shares in treasury.
The figure of 41,672,156 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
For and on behalf of
For further information, please contact:
Tel: 020 3 170 4913